Law Firm’s Investigation Finds Merck Innocent

Law360, New York (September 8, 2006, 12:00 AM EDT) -- Merck & Co. Inc.’s senior management did not knowingly put patients at risk and acted with scientific integrity during the rise and fall of its blockbuster arthritis drug Vioxx, according to an independent report commissioned by the drug maker.

The investigation, which took 20 months and cost $21 million, concluded that Merck scientists did not know Vioxx caused a higher rate of heart attacks and strokes prior to withdrawing the drug from the market in September 2004.

“Critics contend that senior officials at Merck knowingly put...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.